6310 NANCY RIDGE DRIVE, SAN DIEGO, CA
Market cap: $5.6B (12/18/2025)
Price: $220.80
To Acquire Cidara Therapeutics, Diversifying Its Portfolio to Include Late-Phase Antiviral Agent
Provides Corporate Update and Reports Third Quarter 2025 Financial Results
Material Contracts
Other Events
Provides Corporate Update and Reports Second Quarter 2025 Financial Results
Announces Pricing of Upsized Public Offering of Common Stock
Investor Presentation
Q3
Q2
Q1
FY 2024
FY 2023
Solicitation/Recommendation Statement
Tender Offer Statement by Third Party
Schedule 14D-9C Solicitation/Recommendation Statement Communication
Tender Offer Statement by Issuer
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Amended Schedule 13G - Ownership Report
Amended Schedule 14D-9 Solicitation/Recommendation Statement
Amended Tender Offer Statement by Third Party